Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wasting in cancer

M J Tisdale1

  • 1Pharmaceutical Sciences Institute, Aston University, Birmingham B4 7ET, United Kingdom.

The Journal of Nutrition
|January 23, 1999
PubMed
Summary
This summary is machine-generated.

Cancer cachexia, characterized by progressive weight loss, impacts quality of life and survival. Eicosapentaenoic acid (EPA) shows promise in stabilizing weight and muscle mass in patients with pancreatic cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCg) Attenuates Skeletal Muscle Atrophy in a Rat Model of Sarcopenia.

The Journal of frailty & aging·2016
Same author

Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle.

British journal of cancer·2014
Same author

Role of Ca2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle.

Cellular signalling·2012
Same author

Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).

British journal of cancer·2011
Same author

Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat.

International journal of obesity (2005)·2010
Same author

Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse.

International journal of obesity (2005)·2010

Area of Science:

  • Oncology
  • Metabolism
  • Biochemistry

Background:

  • Cancer cachexia is a complex syndrome causing significant weight loss, impacting patient quality of life, chemotherapy response, and survival.
  • While anorexia contributes, it doesn't fully explain body composition changes; increased nutrient intake is often insufficient to reverse wasting.
  • Cachexia involves increased energy expenditure in some, but can occur even with normal energy expenditure, suggesting other mechanisms are at play.

Purpose of the Study:

  • To investigate the mechanisms underlying tissue wasting in cancer cachexia.
  • To identify key mediators, including cytokines and tumor-derived factors, involved in fat and muscle mobilization.
  • To evaluate the potential of eicosapentaenoic acid (EPA) in mitigating cancer cachexia.

Main Methods:

Related Experiment Videos

  • Examined the roles of cytokines like TNF-alpha, IL-6, IFN-gamma, and LIF in cachexia.
  • Investigated tumor-derived factors such as lipid mobilizing factor (LMF) and protein mobilizing factor (PMF).
  • Assessed the impact of eicosapentaenoic acid (EPA) on LMF and PMF activity and clinical outcomes in cancer patients.

Main Results:

  • Cancer cachexia involves increased activity of the ATP-ubiquitin-proteasome pathway for protein degradation.
  • Lipid mobilization is linked to increased hormone sensitive lipase activity, not lipoprotein lipase inhibition.
  • Eicosapentaenoic acid (EPA) demonstrated the ability to attenuate LMF and PMF activity.

Conclusions:

  • Cancer cachexia involves complex molecular mechanisms including cytokine and tumor-derived factors.
  • Eicosapentaenoic acid (EPA) shows therapeutic potential by stabilizing weight loss and preserving adipose and muscle mass in cachectic patients.
  • Understanding these mechanisms is crucial for developing novel therapeutic strategies against cancer cachexia.